- Home
- DIAX vs RXST Comparison
DIAX vs RXST Comparison
Compare DIAX & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DIAX | RXST |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 553.9M | 524.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | DIAX | RXST |
|---|---|---|
| Price | $15.51 | $9.56 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $11.30 |
| AVG Volume (30 Days) | 96.6K | ★ 720.5K |
| Earning Date | 01-01-0001 | 02-24-2026 |
| Dividend Yield | ★ 7.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $142,085,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 10.75 |
| 52 Week Low | $12.80 | $6.32 |
| 52 Week High | $15.12 | $37.13 |
Technical Indicators
Market Signals| Indicator | DIAX | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 66.53 | 32.63 |
| Support Level | $15.10 | $10.22 |
| Resistance Level | $15.38 | $13.14 |
| Average True Range (ATR) | 0.18 | 0.56 |
| MACD | 0.03 | -0.31 |
| Stochastic Oscillator | 84.81 | 0.15 |
Price Performance
Historical ComparisonAbout DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.